Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07174570
What this trial is testing

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more
Emory University 39
Not applicableEnded earlyNCT02787954
What this trial is testing

Prospective Tumor Response Evaluation

Who this might be right for
Hepatocellular CancerMetastatic Liver Cancer
The University of Texas Health Science Center, Houston 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07537946
What this trial is testing

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastases
Tongji Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT06349980
What this trial is testing

Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Henlius Biotech 117
Testing effectiveness (Phase 2)Looking for participantsNCT07274774
What this trial is testing

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 184
Testing effectiveness (Phase 2)Study completedNCT01507168
What this trial is testing

GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 185
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Study completedNCT01498952
What this trial is testing

MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.

Who this might be right for
Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
MedImmune LLC 6
Early research (Phase 1)Study completedNCT00441376
What this trial is testing

ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

Who this might be right for
Hepatocellular CarcinomaLiver Neoplasms
Imunon 30
Early research (Phase 1)Looking for participantsNCT06600321
What this trial is testing

Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
Alnylam Pharmaceuticals 158
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Testing effectiveness (Phase 2)Study completedNCT03044587
What this trial is testing

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer

Who this might be right for
Adenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more
AIO-Studien-gGmbH 93
Testing effectiveness (Phase 2)Study completedNCT01935700
What this trial is testing

Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMetastasisInvasion
Kaohsiung Medical University Chung-Ho Memorial Hospital 15
Early research (Phase 1)Ended earlyNCT01219543
What this trial is testing

A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Who this might be right for
Solid TumourAdvanced Solid MalignanciesChild-Pugh A to B7 Advanced Hepatocellular Carcinoma+3 more
AstraZeneca 47
Early research (Phase 1)Study completedNCT00746317
What this trial is testing

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Advanced or Metastatic HCC
Chugai Pharmaceutical 27
Not applicableEnded earlyNCT02881554
What this trial is testing

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

Who this might be right for
Hepatocellular CarcinomaIntrahepatic CholangiocarcinomaStage IV Liver Cancer+3 more
University of Washington 41
Not applicableLooking for participantsNCT07445412
What this trial is testing

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

Who this might be right for
Liver TumoursLiver Cancer (Primary and Metastatic)Liver Resection+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 2,000
Testing effectiveness (Phase 2)Study completedNCT00191412
What this trial is testing

Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

Who this might be right for
Liver Cancer
Eli Lilly and Company 41
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Not applicableUnknownNCT05986383
What this trial is testing

Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree

Who this might be right for
Primary Liver CancerMetastatic Liver CancerBenign Liver Neoplasms+1 more
Beijing Tsinghua Chang Gung Hospital 820
Next Page